Contact this trialFirst, we need to learn more about you.
Placebo +1 More for Primary Sclerosing Cholangitis
Recruiting0 awardsPhase 2
Chestnut Hill, Massachusetts
This trial will test whether sulfasalazine can help treat symptoms and reduce liver injury markers in patients with primary sclerosing cholangitis.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.